BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 26154707)

  • 1. New insights in the management of patients with hairy cell leukemia.
    Cornet E; Damaj G; Troussard X
    Curr Opin Oncol; 2015 Sep; 27(5):371-6. PubMed ID: 26154707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Historical overview of hairy cell leukemia.
    Andritsos LA; Grever MR
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):166-74. PubMed ID: 26614894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hairy cell leukemia: update and current therapeutic approach.
    Salam L; Abdel-Wahab O
    Curr Opin Hematol; 2015 Jul; 22(4):355-61. PubMed ID: 26049757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hairy cell leukemia: Past, present and future.
    Getta BM; Park JH; Tallman MS
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):269-72. PubMed ID: 26614906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the biology and treatment options for hairy cell leukemia.
    Jain P; Pemmaraju N; Ravandi F
    Curr Treat Options Oncol; 2014 Jun; 15(2):187-209. PubMed ID: 24652320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairy cell leukemia: a 'hair-raising' update.
    Topp ZZ; Saven A
    Expert Rev Hematol; 2014 Oct; 7(5):659-69. PubMed ID: 25148599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF inhibitor therapy in HCL.
    Dietrich S; Zenz T
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):246-52. PubMed ID: 26614903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular and therapeutic advances in Hairy cell leukemia].
    Balsat M; Cornillon J
    Bull Cancer; 2013 Oct; 100(10):1043-7. PubMed ID: 24103785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF inhibitors reverse the unique molecular signature and phenotype of hairy cell leukemia and exert potent antileukemic activity.
    Pettirossi V; Santi A; Imperi E; Russo G; Pucciarini A; Bigerna B; Schiavoni G; Fortini E; Spanhol-Rosseto A; Sportoletti P; Mannucci R; Martelli MP; Klein-Hitpass L; Falini B; Tiacci E
    Blood; 2015 Feb; 125(8):1207-16. PubMed ID: 25480661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and diagnosis of hairy cell leukemia.
    Quest GR; Johnston JB
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):180-92. PubMed ID: 26614896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
    Maitre E; Cornet E; Troussard X
    Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRAF inhibition in refractory hairy-cell leukemia.
    Dietrich S; Glimm H; Andrulis M; von Kalle C; Ho AD; Zenz T
    N Engl J Med; 2012 May; 366(21):2038-40. PubMed ID: 22621641
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential breakthroughs with investigational drugs for hairy cell leukemia.
    Robak T; Wolska A; Robak P
    Expert Opin Investig Drugs; 2015; 24(11):1419-31. PubMed ID: 26329588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment options in hairy cell leukemia and hairy cell leukemia variant.
    Robak T
    Cancer Treat Rev; 2006 Aug; 32(5):365-76. PubMed ID: 16781083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up after purine analogue therapy in hairy cell leukaemia.
    Else M; Dearden CE; Catovsky D
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):217-29. PubMed ID: 26614900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splenic diffuse red pulp small-B cell lymphoma: toward the emergence of a new lymphoma entity.
    Traverse-Glehen A; Baseggio L; Salles G; Coiffier B; Felman P; Berger F
    Discov Med; 2012 Apr; 13(71):253-65. PubMed ID: 22541613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia.
    Dearden C
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):163-5. PubMed ID: 26614893
    [No Abstract]   [Full Text] [Related]  

  • 18. Hairy cell leukemia-new genes, new targets.
    Kreitman RJ
    Curr Hematol Malig Rep; 2013 Sep; 8(3):184-95. PubMed ID: 23892906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continued response off treatment after BRAF inhibition in refractory hairy cell leukemia.
    Dietrich S; Hüllein J; Hundemer M; Lehners N; Jethwa A; Capper D; Acker T; Garvalov BK; Andrulis M; Blume C; Schulte C; Mandel T; Meissner J; Fröhling S; von Kalle C; Glimm H; Ho AD; Zenz T
    J Clin Oncol; 2013 Jul; 31(19):e300-3. PubMed ID: 23690412
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoconjugates in the management of hairy cell leukemia.
    Kreitman RJ; Pastan I
    Best Pract Res Clin Haematol; 2015 Dec; 28(4):236-45. PubMed ID: 26614902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.